Entera Bio Statistics

Total Valuation

Entera Bio has a market cap or net worth of $95.38 million. The enterprise value is $85.63 million.

Market Cap	95.38M
Enterprise Value	85.63M

Important Dates

The next estimated earnings date is Friday, May 9, 2025, after market close.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Entera Bio has 45.42 million shares outstanding. The number of shares has increased by 29.79% in one year.

Current Share Class	45.42M
Shares Outstanding	45.42M
Shares Change (YoY)	+29.79%
Shares Change (QoQ)	+3.89%
Owned by Insiders (%)	1.86%
Owned by Institutions (%)	3.59%
Float	22.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	519.45
Forward PS	n/a
PB Ratio	9.95
P/TBV Ratio	11.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	473.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.63, with a Debt / Equity ratio of 0.03.

Current Ratio	7.63
Quick Ratio	7.47
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -103.34% and return on invested capital (ROIC) is -62.64%.

Return on Equity (ROE)	-103.34%
Return on Assets (ROA)	-56.64%
Return on Invested Capital (ROIC)	-62.64%
Return on Capital Employed (ROCE)	-116.69%
Revenue Per Employee	$9,050
Profits Per Employee	-$477,050
Employee Count	20
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, Entera Bio has paid $14,000 in taxes.

Income Tax	14,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.44% in the last 52 weeks. The beta is 1.48, so Entera Bio's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	+2.44%
50-Day Moving Average	1.92
200-Day Moving Average	1.92
Relative Strength Index (RSI)	66.69
Average Volume (20 Days)	32,111

Short Selling Information

Short Interest	74,749
Short Previous Month	86,138
Short % of Shares Out	0.16%
Short % of Float	0.34%
Short Ratio (days to cover)	1.40

Income Statement

In the last 12 months, Entera Bio had revenue of $181,000 and -$9.54 million in losses. Loss per share was -$0.25.

Revenue	181,000
Gross Profit	9,000
Operating Income	-9.59M
Pretax Income	-8.51M
Net Income	-9.54M
EBITDA	-9.54M
EBIT	-9.59M
Loss Per Share	-$0.25

Full Income Statement

Balance Sheet

The company has $8.66 million in cash and $272,000 in debt, giving a net cash position of $8.39 million or $0.18 per share.

Cash & Cash Equivalents	8.66M
Total Debt	272,000
Net Cash	8.39M
Net Cash Per Share	$0.18
Equity (Book Value)	8.08M
Book Value Per Share	0.21
Working Capital	7.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.82 million and capital expenditures -$3,000, giving a free cash flow of -$6.82 million.

Operating Cash Flow	-6.82M
Capital Expenditures	-3,000
Free Cash Flow	-6.82M
FCF Per Share	-$0.15

Full Cash Flow Statement

Margins

Gross Margin	4.97%
Operating Margin	-5,295.58%
Pretax Margin	-5,263.54%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Entera Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.79%
Shareholder Yield	-29.79%
Earnings Yield	-10.15%
FCF Yield	-7.25%

Analyst Forecast

The average price target for Entera Bio is $10.00, which is 376.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	376.19%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Entera Bio has an Altman Z-Score of 9.14 and a Piotroski F-Score of 1.

Altman Z-Score	9.14
Piotroski F-Score	1